Susquehanna International Group, LLP Harrow Health, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$10.0 - $21.64 $30,000 - $64,920	-3,000 Reduced 1.59%	186,000 $3.89 Million
Q1 2024 May 07, 2024	BUY	$9.3 - $13.23 $1.04 Million - $1.47 Million	111,400 Added 143.56%	189,000 $2.5 Million
Q4 2023 Feb 14, 2024	SELL	$8.1 - $16.36 $976,860 - $1.97 Million	-120,600 Reduced 60.85%	77,600 $869,000
Q3 2023 Nov 14, 2023	BUY	$14.03 - $22.08 $730,963 - $1.15 Million	52,100 Added 35.66%	198,200 $2.85 Million
Q2 2023 Aug 11, 2023	BUY	$17.37 - $28.08 $2.21 Million - $3.57 Million	127,200 Added 673.02%	146,100 $2.78 Million
Q1 2023 May 16, 2023	SELL	$13.84 - $21.46 $398,592 - $618,048	-28,800 Reduced 60.38%	18,900 $399,000
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $490,355 - $705,006	47,700 New	47,700 $704,000

121

19.7M

700K

575K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.2B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.